Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Clinical Pharmacology Approaches to Predict Efficacy of Monoclonal Antibodies Against Emerging SARS-CoV-2 Variants.
Journal: Clinical and translational science
Published: September 18, 2025
Safety, Tolerability and Pharmacokinetics of a High-Dose, Rapid-Infusion Monoclonal Antibody: Phase I Results for Intravenous Sotrovimab 3000 mg.
Journal: Drugs in R&D
Published: April 04, 2025
Pharmacokinetics and Safety of Single-Dose Sotrovimab in High-Risk Children and Adolescents With Mild-to-Moderate COVID-19.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: March 27, 2025
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study.
Journal: mAbs
Published: January 30, 2025
Pharmacokinetics of the Monoclonal Antibody, Sotrovimab, in Healthy Participants Following IM Administration at Different Injection Sites.
Journal: Clinical pharmacology and therapeutics
Published: May 17, 2024
Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
Journal: Dermatology and therapy
Published: November 07, 2023
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial.
Journal: Infectious diseases and therapy
Published: October 23, 2023
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial.
Journal: Open forum infectious diseases
Published: June 26, 2023
Population pharmacokinetics and exposure-response analysis of a single dose of sotrovimab in the early treatment of patients with mild to moderate COVID-19.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 23, 2022
Lessons from resistance analysis in clinical trials of IV zanamivir.
Journal: Virus research
Published: October 06, 2022
Last Updated: 09/26/2026